Recent Finacing
Recent Raise
ImmunGene develops antibody-cytokine fusion therapies, focusing on antibody-interferon constructs to target interferon to tumors and minimize systemic toxicity for treatment of multiple human cancers.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor